104,063 Shares in Hercules Capital, Inc. $HTGC Purchased by Triad Investment Management

Triad Investment Management bought a new stake in Hercules Capital, Inc. (NYSE:HTGC) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 104,063 shares of the financial services provider’s stock, valued at approximately $1,958,000. Hercules Capital accounts for approximately 2.0% of Triad Investment Management’s investment portfolio, making the stock its 21st largest position. Triad Investment Management owned about 0.06% of Hercules Capital as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in HTGC. Integrated Wealth Concepts LLC grew its position in Hercules Capital by 5.9% during the first quarter. Integrated Wealth Concepts LLC now owns 17,241 shares of the financial services provider’s stock valued at $331,000 after purchasing an additional 959 shares in the last quarter. Empowered Funds LLC boosted its stake in shares of Hercules Capital by 85.9% during the 1st quarter. Empowered Funds LLC now owns 22,854 shares of the financial services provider’s stock valued at $439,000 after buying an additional 10,559 shares during the period. Focus Partners Wealth boosted its stake in shares of Hercules Capital by 26.0% during the 1st quarter. Focus Partners Wealth now owns 15,747 shares of the financial services provider’s stock valued at $302,000 after buying an additional 3,250 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Hercules Capital by 81.8% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 4,780 shares of the financial services provider’s stock valued at $87,000 after acquiring an additional 2,151 shares in the last quarter. Finally, Quantbot Technologies LP increased its stake in shares of Hercules Capital by 745.7% in the second quarter. Quantbot Technologies LP now owns 141,787 shares of the financial services provider’s stock worth $2,592,000 after acquiring an additional 125,022 shares during the last quarter. 19.69% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on HTGC. Weiss Ratings lowered Hercules Capital from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, February 24th. UBS Group dropped their target price on Hercules Capital from $19.50 to $15.00 and set a “neutral” rating on the stock in a research report on Friday, March 13th. Piper Sandler downgraded Hercules Capital from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $20.50 to $17.50 in a research note on Friday, February 13th. Wall Street Zen lowered Hercules Capital from a “buy” rating to a “hold” rating in a report on Saturday, December 20th. Finally, Keefe, Bruyette & Woods dropped their price objective on Hercules Capital from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Friday, February 13th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Hercules Capital currently has an average rating of “Moderate Buy” and an average price target of $18.71.

Insider Transactions at Hercules Capital

In other news, Director Robert P. Badavas purchased 5,000 shares of the company’s stock in a transaction dated Friday, February 27th. The shares were bought at an average price of $14.27 per share, with a total value of $71,350.00. Following the completion of the transaction, the director directly owned 122,073 shares in the company, valued at $1,741,981.71. This trade represents a 4.27% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Seth H. Meyer acquired 7,000 shares of Hercules Capital stock in a transaction dated Friday, February 27th. The stock was purchased at an average price of $14.33 per share, with a total value of $100,310.00. Following the completion of the purchase, the chief financial officer directly owned 448,553 shares of the company’s stock, valued at $6,427,764.49. The trade was a 1.59% increase in their position. The SEC filing for this purchase provides additional information. In the last quarter, insiders acquired 117,015 shares of company stock worth $1,749,620. 1.80% of the stock is currently owned by company insiders.

Hercules Capital Stock Down 1.5%

HTGC stock opened at $14.55 on Thursday. The firm has a market cap of $2.67 billion, a PE ratio of 7.95 and a beta of 0.83. Hercules Capital, Inc. has a 1 year low of $13.70 and a 1 year high of $19.67. The company has a fifty day simple moving average of $15.68 and a 200 day simple moving average of $17.38. The company has a current ratio of 1.48, a quick ratio of 1.48 and a debt-to-equity ratio of 1.03.

Hercules Capital (NYSE:HTGC) last posted its earnings results on Thursday, February 12th. The financial services provider reported $0.48 EPS for the quarter, hitting the consensus estimate of $0.48. Hercules Capital had a net margin of 63.80% and a return on equity of 15.97%. The firm had revenue of $133.25 million for the quarter, compared to the consensus estimate of $141.57 million. During the same period in the prior year, the business posted $0.49 earnings per share. Sell-side analysts anticipate that Hercules Capital, Inc. will post 1.96 EPS for the current fiscal year.

Hercules Capital Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 4th. Stockholders of record on Wednesday, February 25th were issued a dividend of $0.07 per share. The ex-dividend date of this dividend was Wednesday, February 25th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.9%. Hercules Capital’s dividend payout ratio is currently 87.43%.

Trending Headlines about Hercules Capital

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: There was a brief intraday bounce noted recently, showing the stock can rally on short‑term flows despite pressure — a sign traders can create short‑term moves even as headlines turn negative. Hercules Capital (HTGC) Advances
• Neutral Sentiment: Valuation and investor‑note pieces are re‑examining whether current prices reflect long‑term value vs. near‑term risk; these analyses are useful for longer‑term shareholders weighing whether recent weakness is a buying opportunity or warning sign. Is It Time To Reassess Hercules Capital?
• Negative Sentiment: Hagens Berman filed a securities class action after the Hunterbrook report; the complaint cites alleged copying of Google Ventures sourcing, misstated marks and questions about PIK loans — allegations that directly target the firm’s underwriting and disclosure practices. Hagens Berman Class Action Notice
• Negative Sentiment: Multiple plaintiff firms (Glancy, Faruqi, Pomerantz, Rosen, Levi & Korsinsky, Robbins, Schall, etc.) are actively soliciting lead plaintiffs and reminding investors of a May 19, 2026 deadline — the concentrated legal solicitations amplify headline risk and the probability of expensive, drawn‑out litigation. Glancy Lead Plaintiff Notice
• Negative Sentiment: Some firms quantify near‑term investor damages (Levi & Korsinsky citing a $1.22 per‑share decline after the corrective report) and analysts/columnists warn that any software‑sector markdowns or loan revaluations could turn the apparent valuation discount into realized losses. That elevates downside risk for holders. Levi & Korsinsky Investor Alert

Hercules Capital Profile

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company’s investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.